Lung Neuroendocrine Tumor G2
2 clinical trials · Condition
◉ Watch Lung Neuroendocrine Tumor G2
| Record | Firm | Date |
|---|---|---|
| Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors (NCT04665739) | National Cancer Institute (NCI) | 2023-02-03 |
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (NCT03375320) | National Cancer Institute (NCI) | 2018-10-26 |
Track Lung Neuroendocrine Tumor G2 automatically
Every clearance here is in the API, with alerts when new ones post.